secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longboard Pharmaceuticals, Inc. (—)
CIK:        0001832168
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0000950170-24-064559
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.07, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longboard shareholders approve officer exculpation amendment; director Jane Tiller resigns
--------------------------------------------------------------------------------

- Shareholders approved Officer Exculpation Amendment limiting officer liability under Delaware law (25.2M for, 4.7M against).
- Director Jane Tiller resigned effective May 23, 2024, due to change in primary employment; no disagreement with company.
- Paul J. Sekhri and Phillip M. Schneider elected as Class III directors until 2027 annual meeting.
- KPMG LLP ratified as independent auditor for fiscal year ending Dec 31, 2024 (30.7M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832168/000095017024064559/0000950170-24-064559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832168/000095017024064559/lbph-20240523.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-064559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer